Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125320031 | 12532003 | 1 | I | 20160630 | 20160706 | 20160706 | EXP | US-ABBVIE-16P-163-1669042-00 | ABBVIE | O^CONNELL C, HORWOOD K, NADAMUNI M. CORRECTION OF REFRACTORY THROMBOCYTOPENIA AND ANEMIA FOLLOWING WITHDRAWAL OF EXTENDED RELEASE NIACIN. AMERICAN JOURNAL OF HEMATOLOGY. 2016;91(7):E318-E318. | 67.00 | YR | M | Y | 0.00000 | 20160706 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125320031 | 12532003 | 1 | PS | NIACIN ER | NIACIN | 1 | Oral | Y | Y | UNKNOWN | 20381 | 1000 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125320031 | 12532003 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125320031 | 12532003 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125320031 | 12532003 | Thrombocytopenia | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |